NCT06619327

Brief Summary

This study will evaluate the feasibility and preliminary efficacy of the novel Resilient Together for Dementia (RT-D) intervention for couples following dementia diagnoses. The primary target is emotional distress, and the program aims to prevent chronic distress in at-risk couples.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
25mo left

Started Feb 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Feb 2025Jul 2028

First Submitted

Initial submission to the registry

September 26, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

February 19, 2025

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

June 4, 2026

Status Verified

June 1, 2026

Enrollment Period

2.4 years

First QC Date

September 26, 2024

Last Update Submit

June 2, 2026

Conditions

Keywords

DementiaCare partnersDyadsEmotional distressQuality of lifeCouples

Outcome Measures

Primary Outcomes (5)

  • Proportion of participants screened

    Feasibility of recruitment - recruitment will be monitored by screening clinic visits for potentially eligible individuals and review recruitment progress in weekly meetings to promote completion within the study time frame. The research team will measure with the proportion of participants screened.

    After each dyad completion, throughout study of 6-8 weeks

  • Proportion of participants who consent or not consent to participate

    Feasibility of consent - by keeping a record of all individuals who complete screening that consent, refuse to consent, and the reasons for refusal will be monitored and will review progress in weekly team meetings. The research team will measure with the proportion of participants who consent or not consent to participate

    After each dyad completion, throughout study of 6-8 weeks

  • Proportion of sessions participants attend

    The number of sessions that enrolled dyads attend as well as missed sessions, treatment dropouts, and reasons for nonattendance will be monitored and will review progress in weekly meetings. The research team will measure with the proportion of sessions participants attend.

    After each dyad completion, throughout study of 6-8 weeks

  • Credibility and Expectancy Questionnaire (CEQ)

    A scale measuring treatment expectancy and rationale credibility for use in clinical outcome studies. Full scale from 0-10, with higher score indicating higher treatment expectancy

    After each dyad completion, throughout study of 6-8 weeks

  • Client Satisfaction Questionnaire

    A 3-item questionnaire assessing participants' satisfaction with participation in the study. Full scale from 0-12, with higher score indicating greater satisfaction.

    After each dyad completion, throughout study of 6-8 weeks

Secondary Outcomes (3)

  • Hospital Anxiety and Depression Scale

    Baseline to posttest (6-8 weeks)

  • Geriatric Depression Scale

    Baseline to posttest (6-8 weeks)

  • Perceived Stress Scale

    Baseline to posttest (6-8 weeks)

Study Arms (1)

Resilient Together for Dementia

EXPERIMENTAL

The research team will compare two programs to reduce emotional distress among couples after dementia diagnosis.

Behavioral: Resilient Together for DementiaBehavioral: MEUC

Interventions

RT-D has been developed based on feedback from couples and dementia clinicians as well as prior successful dyadic interventions. RT-D was developed based on the Recovering Together (RT) dyadic intervention for acute neurological illnesses and is being adapted to address the needs of couples navigating new dementia diagnoses.

Also known as: RT-D
Resilient Together for Dementia
MEUCBEHAVIORAL

The MEUC condition was also developed based on the comparison trial in the Recovering Together dyadic intervention, and was adapted based on feedback from prior studies. The program is self-guided and provides educational information similar to the RT-D condition, but with no skills practice or weekly sessions with a therapist.

Also known as: Minimally enhanced usual care
Resilient Together for Dementia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Recent (\~3 month) chart documented ADRD diagnosis,
  • ADRD symptom onset after age 65
  • Cognitive assessment scores and symptoms consistent with early stage dementia, as determined by the Clinical Dementia Rating Scale scores of .5 or 1.0
  • Cognitive awareness of their problems (as determined by the treating neurologist), and ability to understand study and research protocol, as determined by a standardized teach-back method assessment
  • English speaking adults (18 years or older)
  • Dyad lives together
  • At least one partner endorses clinically significant emotional distress during screening (\>7 on Hospital Anxiety and Depression scale subscales or \<5 on the Geriatric Depression Scale)

You may not qualify if:

  • Patient is deemed inappropriate by the neurology team
  • Either partner has a co-occurring terminal illness
  • Patient was diagnosed with forms of dementia with clinical profiles that would preclude participation (e.g., Frontotemporal Dementia- behavioral variant), as determined by treatment team.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brain Injury Research Center at Mount Sinai

New York, New York, 10029, United States

RECRUITING

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Sarah Bannon, PhD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 26, 2024

First Posted

October 1, 2024

Study Start

February 19, 2025

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2028

Last Updated

June 4, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, please contact sarah.bannon@mountsinai.org

Locations